ReviewCytokine: X2020

SARS-CoV-2 and COVID-19: Is interleukin-6 (IL-6) the 'culprit lesion' of ARDS onset? What is there besides Tocilizumab? SGP130Fc.

Giuseppe MagroPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.